Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017 (2017), Article ID 1960517, 13 pages
https://doi.org/10.1155/2017/1960517
Research Article

Antiarthritic Activity of Qi-Wu Rheumatism Granule (a Chinese Herbal Compound) on Complete Freund’s Adjuvant-Induced Arthritis in Rats

1Department of Immunology, School of Preclinical Medicine, Xinjiang Medical University, Urumqi 830011, China
2Department of Biology, School of Preclinical Medicine, Xinjiang Medical University, Urumqi 830011, China
3Center of Functional Experiment, School of Preclinical Medicine, Xinjiang Medical University, Urumqi 830011, China
4Department of Pharmacology, School of Preclinical Medicine, Xinjiang Medical University, Urumqi 830011, China

Correspondence should be addressed to Lu-feng Cheng; nc.ude.umjx@gnehcfl

Received 27 June 2017; Revised 12 September 2017; Accepted 28 September 2017; Published 7 November 2017

Academic Editor: Young-Su Yi

Copyright © 2017 Qi Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Coiffier, B. Bouvard, F. Chopin et al., “Common bone turnover markers in rheumatoid arthritis and ankylosing spondylitis: a literature review,” Joint Bone Spine, vol. 80, no. 3, pp. 250–257, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. S. E. Gabriel, “The epidemiology of rheumatoid arthritis,” Rheumatic Disease Clinics of North America, vol. 27, no. 2, pp. 269–281, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Gibofsky, “Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis,” The American Journal of Managed Care, vol. 18, no. 13, pp. S295–S302, 2012. View at Google Scholar · View at Scopus
  4. Q. Wang, H. Kuang, Y. Su et al., “Naturally derived anti-inflammatory compounds from Chinese medicinal plants,” Journal of Ethnopharmacology, vol. 146, no. 1, pp. 9–39, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. K. M. Huffman, R. Jessee, B. Andonian et al., “Molecular alterations in skeletal muscle in rheumatoid arthritis are related to disease activity, physical inactivity, and disability,” Arthritis research and therapy, vol. 19, no. 1, p. 12, 2017. View at Google Scholar
  6. M. J. H. Hair, M. G. H. Sande, and T. H. Ramwadhdoebe, “Features of the synovium of individuals at risk of developing rheumatoid arthritis : implications for understanding preclinical rheumatoid arthritis,” Arthritis and Rheumatology, vol. 66, no. 3, pp. 513–522, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. D. A. Walsh and D. F. McWilliams, “Mechanisms, impact and management of pain in rheumatoid arthritis,” Nature Reviews Rheumatology, vol. 10, no. 10, pp. 581–592, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Deane, “Can rheumatoid arthritis be prevented,” Best Practice and Research Clinical Rheumatology, vol. 27, no. 4, pp. 87–92, 2013. View at Google Scholar
  9. S. Ramiro, C. Gaujoux-Viala, J. L. Nam et al., “Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 73, no. 3, pp. 529–535, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Schiff, M. Keiserman, C. Codding et al., “Clinical response and tolerability to abatacept in patients with rheumatoid arthritis previously treated with infliximab or abatacept: Open-label extension of the ATTEST Study,” Annals of the Rheumatic Diseases, vol. 70, no. 11, pp. 2003–2007, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Harmse and H. Reuter, “An overview of the biological disease modifying drugs available for arthritic conditions in South Africa,” South African Family Practice, vol. 58, no. 6, pp. 6–10, 2016. View at Google Scholar
  12. P. Roll, A. Palanichamy, C. Kneitz, T. Dorner, and H.-P. Tony, “Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis,” Arthritis & Rheumatology, vol. 54, no. 8, pp. 2377–2386, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. V. Murunikkara and M. K. Rasool, “Trikatu, a herbal compound mitigates the biochemical and immunological complications in adjuvant-induced arthritic rats,” International Journal of Rheumatic Diseases, vol. 20, no. 3, pp. 298–308, 2017. View at Publisher · View at Google Scholar · View at Scopus
  14. M. C. Huang, F. T. Pai, C. C. Lin et al., “Characteristics of traditional Chinese medicine use in patients with rheumatoid arthritis in Taiwan: a nationwide population-based study,” Journal of Ethnopharmacology, vol. 176, pp. 9–16, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Lu, Q.-I. Zha, A.-I. Chang, Y. T. He, and A.-P. Lu, “Pattern differentiation in traditional chinese medicine can help define specific indications for biomedical therapy in the treatment of rheumatoid arthritis,” The Journal of Alternative and Complementary Medicine, vol. 15, no. 9, pp. 1021–1025, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Qiu, “When the East meets the West: The future of traditional Chinese medicine in the 21st century,” National Science Review, vol. 2, no. 3, pp. 377–380, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. He, A. Ou, X. Yang et al., “Traditional Chinese medicine versus western medicine as used in China in the management of rheumatoid arthritis: a randomized, single-blind, 24-week study,” Rheumatology international, vol. 34, no. 12, pp. 1647–1655, 2014. View at Google Scholar
  18. H. M. Tag, O. E. Kelany, and H. M. Tantawy, “Potential anti-inflammatory effect of lemon and hot pepper extracts on adjuvant-induced arthritis in mice,” The Journal of Basic and Applied Zoology, vol. 67, no. 5, pp. 149–157, 2014. View at Publisher · View at Google Scholar
  19. M. Hegen, J. C. Keith Jr., M. Collins, and C. L. Nickerson-Nutter, “Utility of animal models for identification of potential therapeutics for rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 67, no. 11, pp. 1505–1515, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Zhao, Q. Zha, M. Jiang, H. Cao, and A. Lu, “Expert consensus on the treatment of rheumatoid arthritis with chinese patent medicines,” The Journal of Alternative and Complementary Medicine, vol. 19, no. 2, pp. 111–118, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Coruzzi, M. Adami, E. Guaita, I. J. P. de Esch, and R. Leurs, “Antiinflammatory and antinociceptive effects of the selective histamine H4-receptor antagonists JNJ7777120 and VUF6002 in a rat model of carrageenan-induced acute inflammation,” European Journal of Pharmacology, vol. 563, no. 1-3, pp. 240–244, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Feng-Lai, C. Fei-Hu, L. Wei-Guo et al., “Inhibition of acid-sensing ion channels in articular chondrocytes by amiloride attenuates articular cartilage destruction in rats with adjuvant arthritis,” Inflammation Research, vol. 59, no. 11, pp. 939–947, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. O. Kehoe, A. Cartwright, A. Askari, A. J. El Haj, and J. Middleton, “Intra-articular injection of mesenchymal stem cells leads to reduced inflammation and cartilage damage in murine antigen-induced arthritis,” Journal of Translational Medicine, vol. 12, article 157, 2014. View at Publisher · View at Google Scholar
  24. D. K. Rhee, J. Marcelino, M. Baker et al., “The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth,” The Journal of Clinical Investigation, vol. 115, no. 3, pp. 622–631, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Visser, S. Le Cessie, K. Vos, F. C. Breedveld, and J. M. W. Hazes, “How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis,” Arthritis & Rheumatology, vol. 46, no. 2, pp. 357–365, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. M.-C. Boissier, E. Assier, G. Falgarone, and N. Bessis, “Shifting the imbalance from Th1/Th2 to Th17/treg: The changing rheumatoid arthritis paradigm,” Joint Bone Spine, vol. 75, no. 4, pp. 373–375, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. G. R. Burmester, E. Feist, and T. Dörner, “Emerging cell and cytokine targets in rheumatoid arthritis,” Nature Reviews Rheumatology, vol. 10, no. 2, pp. 77–88, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Hu, R. Mu, J. Zhu et al., “Hypoxia and hypoxia-inducible factor-1α provoke toll-like receptor signalling-induced inflammation in rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 73, no. 5, pp. 928–936, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Sokolove, D. S. Johnson, L. J. Lahey et al., “Rheumatoid factor as a potentiator of anti-citrullinated protein antibody-mediated inflammation in rheumatoid arthritis,” Arthritis & Rheumatology, vol. 66, no. 4, pp. 813–821, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Choy, K. Ganeshalingam, A. G. Semb, Z. Szekanecz, and M. Nurmohamed, “Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment,” Rheumatology, vol. 53, no. 12, pp. 2143–2154, 2014. View at Publisher · View at Google Scholar
  31. Y. Hu, W. Cheng, W. Cai, Y. Yue, J. Li, and P. Zhang, “Advances in research on animal models of rheumatoid arthritis,” Clinical Rheumatology, vol. 32, no. 2, pp. 161–165, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. J. R. O'Dell, T. R. Mikuls, T. H. Taylor et al., “Therapies for active rheumatoid arthritis after methotrexate failure,” The New England Journal of Medicine, vol. 369, no. 4, pp. 307–318, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Calmon-Hamaty, R. Audo, B. Combe, J. Morel, and M. Hahne, “Targeting the Fas/FasL system in Rheumatoid Arthritis therapy: Promising or risky?” Cytokine, vol. 75, no. 2, pp. 228–233, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. H.-M. Liu and K.-J. Wang, “Therapeutic effect of Captopril on rheumatoid arthritis in rats,” Asian Pacific Journal of Tropical Medicine, vol. 7, no. 12, pp. 996–999, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Heo, J.-S. Park, H. J. Jang et al., “Hyaluronan nanoparticles bearing γ-secretase inhibitor: In vivo therapeutic effects on rheumatoid arthritis,” Journal of Controlled Release, vol. 192, pp. 295–300, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Zhao, T. Liu, F. Xu, S. You, C. Li, and Z. Gu, “Anti-arthritic effects of total flavonoids from Juniperus sabina on complete freund's adjuvant induced arthritis in rats,” Pharmacognosy Magazine, vol. 12, no. 47, pp. 178–183, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Pan, T. Cheng, Y. Jia, P. Li, and F. Li, “Anti-rheumatoid arthritis effects of traditional Chinese herb couple in adjuvant-induced arthritis in rats,” Journal of Ethnopharmacology, vol. 205, pp. 1–7, 2017. View at Publisher · View at Google Scholar
  38. G. Murdaca, F. Spano, and F. Puppo, “Use of leflunomide plus TNF-α inhibitors in rheumatoid arthritis,” Expert Opinion on Drug Safety, vol. 12, no. 6, pp. 801–804, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. D. H. Solomon, J. R. Curtis, K. G. Saag et al., “Cardiovascular risk in rheumatoid arthritis: comparing tnf-α blockade with nonbiologic DMARDs,” American Journal of Medicine, vol. 126, no. 8, pp. 730.e9–730.e17, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. W. Ouyang, J. K. Kolls, and Y. Zheng, “The biological functions of T helper 17 cell effector cytokines in inflammation,” Immunity, vol. 28, no. 4, pp. 454–467, 2008. View at Publisher · View at Google Scholar
  41. L. A. Fouser, J. F. Wright, K. Dunussi-Joannopoulos, and M. Collins, “Th17 cytokines and their emerging roles in inflammation and autoimmunity,” Immunological Reviews, vol. 226, no. 1, pp. 87–102, 2008. View at Publisher · View at Google Scholar · View at Scopus